BELLUS Health is Preparing to Voluntarily Delist from the NASDAQ Capi...(stry changes in the regulatory environme...),Health

Date:12/5/2008

stry, changes in the regulatory environment in the jurisdictions in which the BELLUS Health Group does business, stock market volatility, fluctuations in costs, and changes to the competitive environment due to consolidation, that actual results may vary once the final and quality-controlled verification of data and analyses has been completed, as well as other risks disclosed in public filings of BELLUS Health Inc. Consequently, actual future results may differ materially from the anticipated results expressed in the forward-looking statements. The reader should not place undue reliance, if any, on any forward-looking statements included in this news release. These statements speak only as of the date made and BELLUS Health Inc. is under no obligation and disavows any intention to update or revise such statements as a result of any event, circumstances or otherwise, unless required by applicable legislation or regulation. Please see the Annual Information Form of BELLUS Health Inc. for further risk factors that might affect the BELLUS Health Group and its business.

CONTACT: Lise Hebert, Ph.D., Vice President, Corporate Communications, (450) 680-4572, lhebert@bellushealth.com

'/>"/>

SOURCE BELLUS HEALTH INC. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related medicine news :

1. BELLUS Health Announces Stock Listing Transfer from NASDAQ Global Market to NASDAQ Capital Market
2. BELLUS Health Reports Results for Third Quarter of Fiscal 2008 and on EMEA Update
3. BELLUS Health to present at the Rodman and Renshaw 10th Annual Healthcare Conference
4. BELLUS Health provides update on activities
5. BELLUS Health announces closing of Innodia acquisition
6. BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference
7. BELLUS HEALTH reports results for first quarter of fiscal 2008
8. At Annual and Special Meeting of Shareholders - Neurochem to officially adopt new name - BELLUS Health - And to provide update on programs including first new natural health product, VIVIMIND(TM)
9. Health Care Without Harm, WHO Announce Partnership for Global Reduction of Mercury-Based Medical Devices
10. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
11. Aurora Health Care Urges All Wisconsin Residents to Take Vitamin D